NSE › Healthcare

Supriya Lifescience Limited (SUPRIYA)

NSE · Healthcare · Biotechnology

₹879.65+4.66%
Last close · 2026-08-04

Latest quarter · ended 2026-03-31

Revenue
₹277 cr
Revenue YoY
+50.2%
Net profit
₹74 cr
Profit YoY
+47.3%
EPS
₹9.22
EPS estimate
₹6.70
Net margin
26.8%

EPS came in at 9.22 against a street estimate of 6.70 — a beat of 37.6%.

Key statistics

Market cap
₹7,080 cr
P/E
33.8
Forward P/E
0.0
P/B
5.83
Book value
₹148.77
EPS (TTM)
₹26.01
Dividend yield
0.12%
52-week high
₹1,085.00
52-week low
₹545.50
50-day MA
₹900.45
200-day MA
₹746.34
Beta
0.63

Analyst view

with an average price target of ₹940.00.

Shareholding

Promoters
71.28%
Institutions
4.68%

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for Supriya Lifescience Limited — free to start.

Google PlayApp Store

Other Healthcare companies

Sun Pharmaceutical Industries LimitedDivi's Laboratories LimitedTorrent Pharmaceuticals LimitedApollo Hospitals Enterprise LimitedCipla LimitedZydus Lifesciences LimitedLupin LimitedMax Healthcare Institute LimitedMankind Pharma LtdLaurus Labs LimitedLenskart Solutions LtdDr. Reddy's Laboratories Limited

Data updated 2026-08-05.